References
- American College of Obstetricians and Gynecologists. Induction of labor with misoprostol. ACOG Committee Opinion 228. ACOG, Washington, DC 1999
- Meydanlı M, Caliskan E, Burak F, Narin M A, Atmaca R. Labor induction post-term with 25 micrograms vs. 50 micrograms of intravaginal misoprostol. Int J Gynecol Obstet 2003; 81: 249–255
- Caliskan E, Bodur H, Ozeren S, Corakci A, Ozkan S, Yucesoy I. Misoprostol 50 μg sublingually versus vaginally for labor induction at term: a randomized study. Gynecol Obstet Invest 2005; 59: 155–161
- Glantz J C. Elective inductions vs. spontaneous labor associations and outcomes. J Reprod Med 2005; 50: 235–240
- Meydanlı M, Caliskan E, Haberal A. Prediction of adverse outcome associated with vaginal misoprostol for labor induction. Eur J Obstet Gynecol Reprod Biol 2003; 110: 143–148
- Bloom S L, Swindle R G, McIntire D D, Leveno K J. Fetal pulse oximetry: duration of desaturation and intrapartum outcome. Obstet Gynecol 1999; 93: 1036–1040
- Kuhnert M, Seelbach-Goebel B, Butterwegge M. Predictive agreement between the fetal arterial oxygen saturation and fetal scalp pH: results of the German multicenter study. Am J Obstet Gynecol 1998; 178: 330–335
- American College of Obstetricians and Gynecologists. Umblical artery blood acid-base analysis. ACOG Tech Bull 1995, No:216
- Shetty A, Mackie L, Danielian P, Rice P, Templeton A. Sublingual compared with oral misoprostol in term labour induction: a randomised controlled trial. BJOG 2002; 109: 645–650
- Buccellato C A, Stika C S, Frederiksen M C. A randomized trial of misoprostol versus extra-amniotic sodium chloride infusion with oxytocin for induction of labor. Am J Obstet Gynecol 2000; 182: 1039–1044
- Klauser C K, Christensen E E, Chauhan S P, Bufkin L, Magann E F, Bofill J A, Morrison J C. Use of fetal pulse oximetry among high-risk women in labor: a randomized clinical trial. Am J Obstet Gynecol 2005; 192: 1810–1819
- Garite T J, Dildy G A, McNamara H, Nageotte M P, Boehm F H, Dellinger E H, Knuppel R A, Porreco R P, Miller H S, Sunderji S, et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. Am J Obstet Gynecol 2000; 183: 1049–1058
- Sanchez-Ramos L, Kaunitz A M. Misoprostol for cervical ripening and labor induction: a systematic review of the literature. Clin Obstet Gynecol 2000; 43: 475–488
- East C E, Brennecke S P, King J F, Chan F Y, Colditz P B. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). Am J Obstet Gynecol 2006; 194: 606.e1–16
- Kolderup L, McLean L, Grullon K, Stafford K, Kilpatrick S J. Misoprostol is more efficacious for labor induction than prostaglandin E2, but is it associated with more risk. Am J Obstet Gynecol 1999; 180: 1543–1550
- Buser D, Mora G, Arias F. A randomized comparison between misoprostol and dinoprostone for cervical ripening and labor induction in patients with unfavorable cervices. Obstet Gynecol 1997; 89: 581–585
- Wing D A, Maureen P R, Paul R H. A randomized comparison of oral and intravaginal misoprostol for labor induction. Obstet Gynecol 2000; 95: 905–908
- Porreco R P, Boehm F H, Dildy G A, Miller H S, Wickstrom E A, Garite T J, Swedlow D. Dystocia in nulliparas patients monitored with fetal pulse oximetry. Am J Obstet Gynecol 2004; 190: 113–117